 Using immunoblotting, we will determine if the level of S1PR1 expression in peripheral blood leukocytes PBLs is increased in patients with IC pain. Patients will have blood samples taken, at the visit they sign the consent form 3 and 6 months later. A total of 4 teaspoons of blood will be taken for the study. 